2159 — Mediwelcome Healthcare Management & Technology Income Statement
0.000.00%
- HK$91.00m
- HK$67.80m
- CNY321.56m
- 28
- 47
- 54
- 37
Annual income statement for Mediwelcome Healthcare Management & Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 432 | 708 | 323 | 331 | 322 |
Cost of Revenue | |||||
Gross Profit | 96.3 | 93.6 | 32.6 | 29.9 | 51 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 408 | 709 | 410 | 421 | 358 |
Operating Profit | 24.3 | -0.768 | -86.4 | -89.3 | -36.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22.3 | 5.59 | -91 | -96.4 | -45.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22 | 5.2 | -93.7 | -96.1 | -46.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 21 | 4.64 | -89.2 | -94.1 | -45.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 21 | 4.64 | -89.2 | -94.1 | -45.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.197 | 0.071 | -0.469 | -0.359 | -0.157 |